Previous Nav
Net Change on 19-05-2022
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Limited
Cipla Limited
Max Healthcare Institute Limited
Apollo Hospitals Enterprise Limited
IPCA Laboratories Limited
Procter & Gamble Health Limited
Dr. Reddy's Laboratories Limited
Lupin Limited
Alkem Laboratories Limited
Vijaya Diagnostic Centre Limited
Indoco Remedies Limited
Intuitive Surgical Inc
Globus Medical Inc
ICICI Lombard General Insurance Company Limited
Abiomed Inc
Syngene International Limited
Abbott Laboratories
Aarti Drugs Limited
Alembic Pharmaceuticals Limited
Narayana Hrudayalaya Ltd.
Global X Funds - Global X Genomics & Biotechnology ETF
Medplus Health Services Limited
Illumina Inc
Unichem Laboratories Limited
Kovai Medical Center & Hospital Limited
TREPS / Reverse Repo Investments / Corporate Debt Repo
Net Receivables/Payables
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Insurance
Cash
Equity
MFU
DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹1,270.01 crore. DSP Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.
The NAV of DSP Healthcare Fund ended down ₹-0.44(-2.15%)yesterday to ₹19.913.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and
The DSP Healthcare Fund is managed by Vinit Sambre and Jay Kothari.
Mafatlal Centre, 10th Floor, Nariman Point, Mumbai - 400 021